Literature DB >> 24425381

Expression of fatty acid binding protein 4 is involved in the cell growth of oral squamous cell carcinoma.

Doksa Lee1, Koichiro Wada2, Yoshitaka Taniguchi1, Hani Al-Shareef1, Tomotake Masuda1, Yu Usami3, Tomonao Aikawa1, Masaya Okura1, Yoshinori Kamisaki2, Mikihiko Kogo1.   

Abstract

Fatty acid binding proteins (FABPs) are a family of small and highly conserved lipid chaperone molecules with highly varied functions. Among them, fatty acid binding protein 4 (FABP4, also known as aP2) is highly expressed by adipocytes, macrophages and dendritic cells. Although the role of FABP4 in cancer is still unclear, it has been reported to be highly expressed by human tumors such as ovarian and bladder cancers. In the present study, we investigated the expression and role of FABP4 in oral squamous cell carcinoma (SCC) and its expression in oral SCC tissues. Immunohistochemical staining revealed that FABP4 expression in the tumor tissue was much higher than that in the non-tumor area of the same specimen. In the in vitro studies, an FABP4-knockdown SCC cell line (established through FABP4-specific siRNA) showed inhibited growth, and inhibited expression and activation of mitogen-activated protein kinase (MAPK). These results indicate that expression of FABP4 plays an important role in the cell growth of oral SCC through the MAPK pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24425381     DOI: 10.3892/or.2014.2975

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  25 in total

1.  Deregulation of the endogenous C/EBPβ LIP isoform predisposes to tumorigenesis.

Authors:  Valérie Bégay; Jeske J Smink; Christoph Loddenkemper; Karin Zimmermann; Cornelia Rudolph; Marina Scheller; Doris Steinemann; Ulf Leser; Brigitte Schlegelberger; Harald Stein; Achim Leutz
Journal:  J Mol Med (Berl)       Date:  2014-11-18       Impact factor: 4.599

2.  Expression of Adipocyte/Macrophage Fatty Acid-Binding Protein in Tumor-Associated Macrophages Promotes Breast Cancer Progression.

Authors:  Jiaqing Hao; Fei Yan; Yuwen Zhang; Ashley Triplett; Ying Zhang; Debra A Schultz; Yanwen Sun; Jun Zeng; Kevin A T Silverstein; Qi Zheng; David A Bernlohr; Margot P Cleary; Nejat K Egilmez; Edward Sauter; Shujun Liu; Jill Suttles; Bing Li
Journal:  Cancer Res       Date:  2018-02-06       Impact factor: 12.701

3.  Liver fatty acid-binding protein as a diagnostic marker for non-alcoholic fatty liver disease.

Authors:  Erdem Akbal; Erdem Koçak; Ömer Akyürek; Seyfettin Köklü; Hikmetullah Batgi; Mehmet Şenes
Journal:  Wien Klin Wochenschr       Date:  2014-12-02       Impact factor: 1.704

4.  2.5% EMLA Versus 2% Lignocaine with Adrenaline Injection in Small Oral Mucosal Biopsies: A Parallel Group Randomized Controlled Trial.

Authors:  Kirti Chaudhry; Shruti Khatana; Amanjot Kaur; Shailendra Kumar; P G Gigi; G Aparna
Journal:  J Maxillofac Oral Surg       Date:  2020-04-17

Review 5.  Metabolic functions of FABPs--mechanisms and therapeutic implications.

Authors:  Gökhan S Hotamisligil; David A Bernlohr
Journal:  Nat Rev Endocrinol       Date:  2015-08-11       Impact factor: 43.330

6.  FABP4 regulates eosinophil recruitment and activation in allergic airway inflammation.

Authors:  Xiao Na Ge; Idil Bastan; Mythili Dileepan; Yana Greenberg; Sung Gil Ha; Kaylee A Steen; David A Bernlohr; Savita P Rao; P Sriramarao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-04-26       Impact factor: 5.464

Review 7.  Lipids in the tumor microenvironment: From cancer progression to treatment.

Authors:  Kevin C Corn; McKenzie A Windham; Marjan Rafat
Journal:  Prog Lipid Res       Date:  2020-08-11       Impact factor: 16.195

Review 8.  Diverse roles of SIRT1 in cancer biology and lipid metabolism.

Authors:  Glenn E Simmons; Wendy M Pruitt; Kevin Pruitt
Journal:  Int J Mol Sci       Date:  2015-01-05       Impact factor: 5.923

9.  Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells.

Authors:  F Yan; N Shen; J X Pang; Y W Zhang; E Y Rao; A M Bode; A Al-Kali; D E Zhang; M R Litzow; B Li; S J Liu
Journal:  Leukemia       Date:  2016-11-25       Impact factor: 11.528

10.  Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue.

Authors:  Hani Al-Shareef; Shin-Ichiro Hiraoka; Noriaki Tanaka; Yosuke Shogen; Atsushi-Doksa Lee; Sanam Bakhshishayan; Mikihiko Kogo
Journal:  Oncol Rep       Date:  2016-09-21       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.